Blaustein Marc 4
4 · Finch Therapeutics Group, Inc. · Filed Jun 15, 2022
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Award
Common Stock
2022-06-13+35,000→ 36,250 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). One third (1/3) of the total number of RSUs granted vest on October 20, 2022, February 20, 2023 and June 20, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]Includes shares of common stock acquired through the Employee Stock Purchase Plan.